Martindale Pharma improves Aurum pre-filled syringe packaging

Published: 9-Nov-2011
Packaging Regulatory

To ensure ease of use and improve patient safety

Martindale Pharma improves Aurum pre-filled syringe packaging
Martindale Pharma, a UK manufacturer and supplier of pharmaceutical specials, has made a number of improvements to its Aurum range of 11 pre-filled syringes.

The Aurum syringes are used for on-the-spot administration of drugs where high visibility and simple drug identification is crucial.

The Brentwood, Essex-based firm has redesigned the range to enhance ease of use and help improve patient safety. Specific improvements include new colour-differentiated packaging; colour-differentiated translucent boxes that confirm contents; and colour-differentiated labels. In addition the firm has improved tamper-evident labels and the packaging is latex-free and Luer Lock fitting.

The firm says its new colour-differentiated packaging meets national and international colour differentiation standards on syringe labelling and also the Royal College of Anaesthetists recommendations on syringe labelling in critical care.

See more

You may also like

Regulatory
Meet growing chemical containment demands with ControlTech

Meet growing chemical containment demands with ControlTech

Read more
Sherwin-Williams’ advanced coating systems provide robust protection for secondary containment areas: keeping assets, people, the environment, and compliance safe

Trending Articles

  1. FDA escalates action against Dabur India over systemic data-integrity and cGMP failures The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process validation and weaknesses in quality-unit oversight, saying the company's response failed to address the systemic nature of the deficiencies
  2. Why FDA inspectors focus on senior management oversight and quality culture Learn why executive oversight matters, how inspectors evaluate quality culture, and what organisations should do before an inspector arrives on site
  3. FDA inspection readiness: How to prepare for surveillance and pre-approval inspections Learn how to prepare for surveillance and pre-approval inspections, build a culture of continuous compliance and reduce regulatory risk
  4. Beckman Coulter expands Alzheimer’s testing portfolio with CE-marked p-Tau217 assay New blood-based assay and research test aim to improve clinical evaluation and biomarker research for Alzheimer’s disease
  5. Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Andreas Reisse to retire as CEO of SCHOTT Pharma as planned. Christian Mias, Executive Vice President of SCHOTT’s Electronic Packaging Business Unit, appointed as new CEO of SCHOTT Pharma effective May 1st, 2026. Seamless leadership transition ensured

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Regulatory
Meet growing chemical containment demands with ControlTech

Meet growing chemical containment demands with ControlTech

Sherwin-Williams’ advanced coating systems provide robust protection for secondary containment areas: keeping assets, people, the environment, and compliance safe
Manufacturing
FDA escalates action against Dabur India over systemic data-integrity and cGMP failures

FDA escalates action against Dabur India over systemic data-integrity and cGMP failures

The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process validation and weaknesses in quality-unit oversight, saying the company's response failed to address the systemic nature of the deficiencies
Regulatory
Aravax secures FDA Fast Track designation for peanut allergy immunotherapy PVX108

Aravax secures FDA Fast Track designation for peanut allergy immunotherapy PVX108

The designation accelerates development of the peptide-based immunotherapy, which is designed to retrain immune tolerance to peanuts without triggering acute allergic reactions — with Phase II data expected later this year
Regulatory
Tasrif Pharmaceutical granted second US patent for CD155-targeting antibody developed with Abzena's humanisation and immunogenicity platforms

Tasrif Pharmaceutical granted second US patent for CD155-targeting antibody developed with Abzena's humanisation and immunogenicity platforms

Expanded intellectual property supports development of humanised anti-CD155 antibody and next-generation cancer immunotherapy modalities
Regulatory
Promatix secures Innovate UK grant to advance cis-bispecific ADC programme

Promatix secures Innovate UK grant to advance cis-bispecific ADC programme

Funding will support manufacturing scale-up, preclinical studies and IND-enabling safety work for PBS293-exatecan
Regulatory
Why FDA inspectors focus on senior management oversight and quality culture

Why FDA inspectors focus on senior management oversight and quality culture

Learn why executive oversight matters, how inspectors evaluate quality culture, and what organisations should do before an inspector arrives on site
Regulatory
Advanced mass spectrometry technique breaks free from specialist hardware

Advanced mass spectrometry technique breaks free from specialist hardware

Researchers at the University of Warwick and spin-out company Verdel Instruments have successfully demonstrated two-dimensional mass spectrometry (2DMS) on a benchtop instrument, making this powerful technique practical and affordable for everyday laboratory use
Subscribe now